OnCusp Therapeutics
New York, United States · Biopharma, Biotechnology, Health Care
OnCusp Therapeutics is transforming a growing portfolio of cutting-edge molecules into innovative treatments that deliver help and hope to cancer patients worldwide. The company is led by a founding team that has deep experience in business development, clinical development and building start-up biopharmaceutical company. OnCusp continually strives to optimize the largest value inflection point
Key facts
- Headquarters
- New York, United States
- Employees
- 23
- Industries
- Biopharma, Biotechnology, Health Care
- Status
- Private
- Website
- www.oncusptx.com
- Company page
Recent activity at OnCusp Therapeutics
OnCusp Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Jan 2024 | Series A | $100.0M |
Leadership
- Anthony Kim, Chief Financial Officer
- Dimitry S.A. Nuyten, Chief Medical Officer
- Eric Slosberg, Chief Development Officer
- Bing Yuan, Chief Executive Officer
Verified email and direct lines for OnCusp Therapeutics’s decision-makers are on Fundz. See plans
OnCusp Therapeutics in the news
Companies similar to OnCusp Therapeutics
- Newron Pharmaceuticals S.p.A. & EA Pharma Ltd · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Dimerix Limited · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- Cantargia AB · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- BerGenBio ASA · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
- LAVA Therapeutics · Biopharma, Biotechnology, Health Care, Pharmaceutical, Therapeutics
About OnCusp Therapeutics: questions and answers
What does OnCusp Therapeutics do?
OnCusp Therapeutics is transforming a growing portfolio of cutting-edge molecules into innovative treatments that deliver help and hope to cancer patients worldwide. The company is led by a founding team that has deep experience in business development, clinical development and building start-up biopharmaceutical company. OnCusp continually strives to optimize the largest value inflection point
Where is OnCusp Therapeutics headquartered?
OnCusp Therapeutics is headquartered in New York, United States.
How many employees does OnCusp Therapeutics have?
OnCusp Therapeutics has about 23 employees.
Has OnCusp Therapeutics raised funding?
Yes. Fundz has recorded 1 funding event for OnCusp Therapeutics. The most recent, Series A of $100.0M, was in Jan 2024.
Who leads OnCusp Therapeutics?
Bing Yuan is a Chief Executive Officer at OnCusp Therapeutics.
What is the latest news on OnCusp Therapeutics?
On May 14, 2026, OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy